ANIK
Anika Therapeutics Inc
Price:  
26.28 
USD
Volume:  
61,366.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Anika Relative Valuation

-599.3%
Upside

As of 2024-06-17, the Relative Valuation of Anika Therapeutics Inc (ANIK) is (131.21) USD. This relative valuation is based on P/E multiples. With the latest stock price at 26.28 USD, the upside of Anika Therapeutics Inc based on Relative Valuation is -599.3%.

The range of the Relative Valuation is (117.40) - (126.42) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 22.7x - 29.9x 28.4x
Forward P/E multiples 17.4x - 24.4x 22.2x
Fair Price (117.40) - (126.42) (131.21)
Upside -546.7% - -581.0% -599.3%
26.28 USD
Stock Price
(131.21) USD
Fair Price

Anika Relative Valuation - Historical P/E Data

Date P/E
2024-06-17 -5.08
2024-06-14 -5.07
2024-06-13 -5.01
2024-06-12 -5.04
2024-06-11 -4.99
2024-06-10 -4.96
2024-06-07 -4.98
2024-06-06 -5.06
2024-06-05 -5.11
2024-06-04 -5.09
2024-06-03 -5.15
2024-05-31 -4.95
2024-05-30 -4.96
2024-05-29 -4.95
2024-05-28 -4.78
2024-05-24 -4.74
2024-05-23 -4.77
2024-05-22 -4.90
2024-05-21 -4.97
2024-05-20 -4.95
2024-05-17 -4.90
2024-05-16 -4.92
2024-05-15 -5.03
2024-05-14 -4.94
2024-05-13 -4.93
2024-05-10 -4.95
2024-05-09 -4.88
2024-05-08 -5.50
2024-05-07 -5.47
2024-05-06 -5.38
2024-05-03 -5.33
2024-05-02 -5.33
2024-05-01 -5.11
2024-04-30 -5.00
2024-04-29 -5.01
2024-04-26 -4.94
2024-04-25 -4.94
2024-04-24 -5.00
2024-04-23 -4.98
2024-04-22 -5.01
2024-04-19 -4.99
2024-04-18 -4.91
2024-04-17 -4.96
2024-04-16 -4.92
2024-04-15 -4.89
2024-04-12 -4.83
2024-04-11 -4.94
2024-04-10 -4.99
2024-04-09 -5.00
2024-04-08 -4.93